Healthcare

BLS Pharmaceuticals (ASX: BLS) is a profitable and fast-growing healthcare manufacturer that gives ASX investors exposure to some of the more topical corners of the medicines market, including medical cannabis and emerging psychedelic-assisted therapies. Founded in 1998, the company manufactures and distributes therapeutic goods …

• Clinical-trial opportunity in Alzheimer's and neurodegenerative disease research creates a long structural runway

• Xanamem targets cortisol reduction as a novel mechanism for slowing Alzheimer's cognitive decline

ImExHS (ASX: IME), the ASX-listed radiology software and imaging-services group operating primarily across Latin America, has quietly delivered one of the more interesting turnarounds among small-cap healthcare technology names on the exchange. Half-year results released in early September 2026 show aBusinessmoving from thin profitability …

4DMedical (ASX: 4DX) has spent the past year converting a string of regulatory clearances into genuine commercial traction, and its FY26 results give the clearest evidence yet that the Melbourne-based medical-imaging company's core technology is finding a real market, even as theBusinesscontinues to burn …

Ramsay Health Care (ASX: RHC) has delivered a full-year result that looks like the clearest evidence yet that its multi-year turnaround is gaining traction, with double-digitEarningsgrowth across its underlyingBusinessand a major structural announcement — the planned separation of its European arm, Ramsay Santé — …

Ansell Limited (ASX: ANN) does not generate headlines the way a lithium explorer or aFintechdisruptor might, but the maker of protective gloves, industrial safety equipment and single-use medical products has quietly turned in one of the more solid full-year results on the ASX this …